文献速递认知障碍与痴呆

行为变异型阿尔茨海默病的研究标准:系统综述与Meta分析

Research Criteria for the Behavioral Variant of Alzheimer Disease: A Systematic Review and Meta-analysis.
PubMed 文献 · JAMA Neurol · 2022-01-01

该系统综述与Meta分析检索PubMed/MEDLINE和Web of Science至2021年4月7日,评估83项研究(13项适合Meta分析,591例行为变异型阿尔茨海默病(bvAD)患者)。结果显示bvAD行为症状较典型遗忘型阿尔茨海默病(tAD)更严重,临床最似行为变异型额颞叶痴呆(bvFTD),而病理生理特征与tAD共享最多;据此提出bvAD研究标准。

要点

  • bvAD行为症状较tAD更严重(SMD 1.16),较bvFTD有更轻趋势但未达显著(SMD -0.22,P=0.10)。
  • bvAD执行功能较tAD差(SMD -1.03),与bvFTD无显著差异(SMD -0.61,P=0.29)。
  • 神经影像学揭示两种bvAD表型:AD样模式(相对额叶保留)更常见,及更似bvFTD的前部受累模式。

核心结论

  • 数据表明bvAD临床最似bvFTD,而病理生理特征与tAD共享最多;据此提出bvAD研究标准以改进未来研究一致性和可靠性并辅助临床评估。

研究设计与样本

  • 系统综述与随机效应Meta分析,遵循PRISMA指南,检索PubMed/MEDLINE和Web of Science自建库至2021年4月7日,重复检索。
  • 共评估83项研究,其中13项适合Meta分析,收集591例bvAD患者数据。

主要发现

  • bvAD行为症状较tAD更严重(SMD 1.16,95%CI 0.74-1.59,P<.001),较bvFTD有更轻趋势但未达显著(SMD -0.22,95%CI -0.47至0.04,P=.10)。
  • bvAD执行功能较tAD差(SMD -1.03,95%CI -1.74至-0.32,P=.008),与bvFTD无显著差异(SMD -0.61,95%CI -1.75至0.53,P=.29)。
  • bvAD记忆表现较bvFTD差但未达显著(SMD -1.31,95%CI -2.75至0.14,P=.08),与tAD无差异(SMD 0.43,95%CI -0.46至1.33,P=.34)。
  • 神经影像学文献揭示两种bvAD神经影像表型:AD样模式(相对额叶保留)和更似bvFTD模式(额外前部受累),AD样模式更常见。

关键数值与推荐

  • 研究间存在中至高度异质性和中等偏倚风险。
  • bvAD行为症状较tAD的SMD为1.16(95%CI 0.74-1.59,P<.001)。
  • bvAD较bvFTD行为症状的SMD为-0.22(95%CI -0.47至0.04,P=.10)。
  • bvAD执行功能较tAD的SMD为-1.03(95%CI -1.74至-0.32,P=.008)。
  • bvAD记忆表现较bvFTD的SMD为-1.31(95%CI -2.75至0.14,P=.08)。

临床怎么用

  • 作者基于上述见解提出bvAD研究标准,旨在改进未来研究一致性和可靠性并辅助该AD表型的临床评估。

局限性

  • 研究间存在中至高度异质性和中等偏倚风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: The behavioral variant of Alzheimer disease (bvAD) is characterized by early and predominant behavioral deficits caused by AD pathology. This AD phenotype is insufficiently understood and lacks standardized clinical criteria, limiting reliability and reproducibility of diagnosis and scientific reporting. OBJECTIVE: To perform a systematic review and meta-analysis of the bvAD literature and use the outcomes to propose research criteria for this syndrome. DATA SOURCES: A systematic literature search in PubMed/MEDLINE and Web of Science databases (from inception through April 7, 2021) was performed in duplicate. STUDY SELECTION: Studies reporting on behavioral, neuropsychological, or neuroimaging features in bvAD and, when available, providing comparisons with typical amnestic-predominant AD (tAD) or behavioral variant frontotemporal dementia (bvFTD). DATA EXTRACTION AND SYNTHESIS: This analysis involved random-effects meta-analyses on group-level study results of clinical data and systematic review of the neuroimaging literature. The study was performed following Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines. MAIN OUTCOMES AND MEASURES: Behavioral symptoms (neuropsychiatric symptoms and bvFTD core clinical criteria), cognitive function (global cognition, episodic memory, and executive functioning), and neuroimaging features (structural magnetic resonance imaging, [18F]fluorodeoxyglucose-positron emission tomography, perfusion single-photon emission computed tomography, amyloid positron emission tomography, and tau positron emission tomography). RESULTS: The search led to the assessment of 83 studies, including 13 suitable for meta-analysis. Data were collected for 591 patients with bvAD. There was moderate to substantial heterogeneity and moderate risk of bias across studies. Cases with bvAD showed more severe behavioral symptoms than tAD (standardized mean difference [SMD], 1.16 [95% CI, 0.74-1.59]; P < .001) and a trend toward less severe behavioral symptoms compared with bvFTD (SMD, -0.22 [95% CI, -0.47 to 0.04]; P = .10). Meta-analyses of cognitive data indicated worse executive performance in bvAD vs tAD (SMD, -1.03 [95% CI, -1.74 to -0.32]; P = .008) but not compared with bvFTD (SMD, -0.61 [95% CI, -1.75 to 0.53]; P = .29). Cases with bvAD showed a nonsignificant difference of worse memory performance compared with bvFTD (SMD, -1.31 [95% CI, -2.75 to 0.14]; P = .08) but did not differ from tAD (SMD, 0.43 [95% CI, -0.46 to 1.33]; P = .34). The neuroimaging literature revealed 2 distinct bvAD neuroimaging phenotypes: an AD-like pattern with relative frontal sparing and a relatively more bvFTD-like pattern characterized by additional anterior involvement, with the AD-like pattern being more prevalent. CONCLUSIONS AND RELEVANCE: These data indicate that bvAD is clinically most similar to bvFTD, while it shares most pathophysiological features with tAD. Based on these insights, we propose research criteria for bvAD aimed at improving the consistency and reliability of future research and aiding the clinical assessment of this AD phenotype.

来源:JAMA Neurol,查看原文。版权归原作者所有。

引用

  1. Ossenkoppele R, Singleton EH, Groot C, et al. Research Criteria for the Behavioral Variant of Alzheimer Disease: A Systematic Review and Meta-analysis. JAMA Neurol. 2022. PMID: 34870696. doi:10.1001/jamaneurol.2021.4417

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。